Trials / Unknown
UnknownNCT00088673
Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's Disease
A Phase III Study of the Efficacy and Safety of 3APS in Patients With Mild to Moderate Alzheimer's Disease
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 950 (planned)
- Sponsor
- Bellus Health Inc. - a GSK company · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this Phase III study is to evaluate the efficacy and safety of 3APS compared to placebo (inactive substance pill) in patients with mild to moderate Alzheimer's disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 3APS |
Timeline
- Start date
- 2004-06-01
- First posted
- 2004-08-03
- Last updated
- 2007-02-28
Locations
67 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00088673. Inclusion in this directory is not an endorsement.